These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35660215)

  • 1. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and projections of cause-specific premature mortality in Australia to 2044: a statistical modelling study.
    Luo Q; Steinberg J; Kahn C; Caruana M; Grogan PB; Page A; Ivers R; Banks E; O'Connell DL; Canfell K
    Lancet Reg Health West Pac; 2024 Feb; 43():100987. PubMed ID: 38456088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study.
    Damgacioglu H; Sonawane K; Chhatwal J; Lairson DR; Clifford GM; Giuliano AR; Deshmukh AA
    Lancet Reg Health Am; 2022 Apr; 8():100143. PubMed ID: 34927126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.
    GBD 2019 LRI Collaborators
    Lancet Infect Dis; 2022 Nov; 22(11):1626-1647. PubMed ID: 35964613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
    Worthington J; Sun Z; Fu R; Lew JB; Chan KKW; Li Q; Eskander A; Hui H; McLoughlin K; Caruana M; Peacock S; Yong JHE; Canfell K; Feletto E; Malagón T
    PLoS One; 2024; 19(4):e0296945. PubMed ID: 38557758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
    Julien J; Ayer T; Bethea ED; Tapper EB; Chhatwal J
    Lancet Public Health; 2020 Jun; 5(6):e316-e323. PubMed ID: 32504584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma incidence, mortality, and prevalence estimates and projections, Australia, 1982-2043: a statistical modelling study.
    Luo Q; Jenkin D; Weber MF; Steinberg J; White K; Irving A; Rillstone H; Kelly A; Canfell K; Feletto E
    Med J Aust; 2024 Jul; 221(2):103-110. PubMed ID: 39003689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projections of smoking-related cancer mortality in Australia to 2044.
    Luo Q; Steinberg J; Yu XQ; Weber M; Caruana M; Yap S; Grogan PB; Banks E; O'Connell DL; Canfell K
    J Epidemiol Community Health; 2022 Jun; 76(9):792-9. PubMed ID: 35750482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer mortality in Australia: Projected outcomes to 2040.
    Luo Q; Yu XQ; Wade S; Caruana M; Pesola F; Canfell K; O'Connell DL
    Lung Cancer; 2018 Nov; 125():68-76. PubMed ID: 30429040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.